COVID-19 Nucleocapsid IgG Quantitative ELISA Kit


The kit is produced for the quantitative measurement of novel COVID-19 IgG antibody concentration in human serum.
​​​​​​​This kit is for in vitro diagnostics use only.

INTENDED USER This kit is for laboratory professional use or healthcare professionals.


This ELISA kit is designed, developed, and produced for the qualitative measurement of human anti-COVID-19 IgG antibody in serum. This assay utilizes the microplate based enzyme immunoassay technique. Assay calibrators, controls, and 1:100 diluted human serum samples are added to the microtiter wells of a microplate that was coated with COVID-19 recombinant full length nucleocapsid protein. After the first incubation period, the unbound protein matrix is removed with a subsequent washing step. A horseradish peroxidase (HRP) labeled polyclonal goat anti-human IgG tracer antibody is added to each well. After an incubation period, an immunocomplex of "COVID-19 recombinant antigen – human anti-COVID-19 IgG antibody - HRP labeled anti-human IgG tracer antibody" is formed if there is specific coronavirus IgG antibody present in the tested specimen. The unbound tracer antibody is removed by the subsequent washing step. HRP-labeled tracer antibody bound to the well is then incubated with a substrate solution in a timed reaction and then measured in a spectrophotometric microplate reader. The enzymatic activity of the tracer antibody bound to the anti-COVID-19 IgG on the wall of the microtiter well is proportional to the amount of the anti-COVID-19 IgG antibody level in the tested specimen.

Related Products

KT-1032 Coronavirus COVID-19 IgG ELISA Kit
KT-1033 Coronavirus COVID-19 IgM ELISA Kit
KT-1035 Quantitative SARS-CoV-2 Spike Protein IgG ELISA Kit
KT-1036 Quantitative SARS-CoV-2 Neutralizing Antibody ELISA​​​​​​​ Kit

Technical Specifications

For in-vitro diagnostic use.